Antigua and Barbuda vs Norway: Previously treated cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2022
Norway
100.0%
in 2024
Antigua and Barbuda rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Norway
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2009 it was Norway ahead.
Antigua and Barbuda ranks 1st and Norway ranks 1st of 180 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Antigua and Barbuda | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 67.0% | 17.0% | Norway |
| 2010s | 0.0% | 54.3% | 54.3% | Norway |
| 2020s | 100.0% | 67.0% | 33.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Antigua and Barbuda or Norway?
- Antigua and Barbuda, at 100.0% against 100.0% in Norway as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Antigua and Barbuda and Norway?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Norway?
- 5 years are reported by both, from 2009 to 2022.
- How do Antigua and Barbuda and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.